KURA vs VRTX: Which Stock is Better?
Side-by-side comparison of Kura Oncology Inc and Vertex Pharmaceuticals Inc in 2026
KURA
Kura Oncology Inc
$9.68
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | KURA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $793.54M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | -0.7% | 0.1% | VRTX |
| Gross Margin | -272.1% | 53.7% | VRTX |
Analyze KURA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KURA or VRTX a better investment?
Comparing KURA and VRTX: Kura Oncology Inc has a market cap of $793.54M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KURA and VRTX?
KURA (Kura Oncology Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KURA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KURA or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.7% for KURA.
Which company is more profitable: KURA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -272.1% for KURA.
Which is the larger company: KURA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $793.54M for KURA.
Should I buy KURA or VRTX in 2026?
Both KURA and VRTX have investment merit. KURA trades at $9.68 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KURA and VRTX stock?
Key differences: Market Cap ($793.54M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (-0.7% vs 0.1%), Gross Margin (-272.1% vs 53.7%).